期刊文献+

老年肿瘤患者血清促红细胞生成素变化及其与化疗的关系 被引量:2

Relationship between level of serum erythropoietin and chemotherapy in elderly patients with cancer
原文传递
导出
摘要 目的分析老年肿瘤患者血清促红细胞生成素(Epo)水平及其与血红蛋白(Hb)的关系,以及化疗对其的影响。方法应用ELISA方法检测老年肿瘤患者血清Epo,并观察化疗后Epo变化。结果(1)老年组Epo为(22.0±15.1)U/L,与对照组(30.4±21.8)U/L比较,差异无统计学意义(t=1.2988,P〉0.05);Epo水平与Hb水平存在负相关关系(r=-0.3700,P〈0.01);(2)55例Hb正常者Epo为(14.7±10.6)U/L,22例轻度贫血者(20.2±9.0)U/L,23例中重度贫血者(42.3±24.8)U/L,差异有统计学意义(F=11.6886,P〈0.01);(3)化疗4周期和2周期后,贫血组Epo分别为(45.2±39.1)U/L和(25.8±15.9)U/L,与治疗前的(20.2±10.8)U/L比较,差异有统计学意义(F一4.5477,P%0.01);Hb分别为(96.8±16.6)g/L和(102.1±19.3)g/L,与治疗前的(111.0±20.5)g/L比较,差异有统计学意义(F=4.0071,P〈0.01)。结论老年肿瘤患者与非老年肿瘤患者比较,Epo水平差异无统计学意义;贫血患者Epo水平明显高于无贫血患者;Epo水平与Hb值呈负相关关系;化疗可以引起部分患者发生贫血,并且随着化疗周期的增加,Hb值下降而Epo水平升高。 Objective To study the relationship between serum erythropoietin (Epo) level and chemotherapy-induced hemoglobin (Hb) level in elderly patients with cancer. Methods One hundred senile patients (aged≥60 years) with cancer and one hundred and seventy non-senile patients (aged 〈60 years) with cancer were selected as aged group and control group, respectively. The serum Epo level was detected by enzyme-linked immunosorbent assay (ELISA). Results (1)The average levels of the serum Epo in aged group and control group were (22.0±15.1) U/L and (30.4±21.8) U/L,respectively (t= 1. 2988,P〉0.05). A negative correlation was found between the levels of Epo and Hb in elder cancer patients(r=-0. 3700, P〈0. 001). (2)The levels of serum Epo were (14.7± 10.6) U/L, (20.2±9.0) U/L and (42.3±24.8) U/L in 55 cases with normal Hb level,22 cases with mild anemia and 23 cases with moderate to severe anemia, respectively(F=11. 6886,P〈0.01). (3) The levels of Epo were(20.2 ±10. 8) U/L, (45.2 ± 39. 1) U/L and (25.8 ± 15.9) U/L before chemotherapy, after 4 treatment cycles and 2 treatment cycles respeetively(F=4. 5477,P〈0.01). The levels of Hb were (111.0±20.5)g/L, (96.8± 16.6)g/L and (102.1± 19.3)g/L before chemotherapy, after 4 treatment cycles and 2 treatment cycles respeetively(F= 4. 0071 ,P〈0.01). Conclusions There is no statistical difference in serum Epo level between senile patients with cancer and non-senile patients with cancer, but serum Epo level is higher in patients with anemia than without anemia. There is a negative correlation between the levels of Epo and Hb. Chemotherapy can decrease the level of Hb and increase the serum level of Epo in part of patients. The changes are correlated with the conditions of patients before chemotherapy and the time of chemotherapy.
出处 《中华老年医学杂志》 CAS CSCD 北大核心 2009年第2期113-115,共3页 Chinese Journal of Geriatrics
关键词 肿瘤 贫血 红细胞生成素 血红蛋白 Tumors Anemia Erythropoietin Hemoglobins
  • 相关文献

参考文献10

  • 1Heinz L, Simon B, Peter BE, et al. The European Cancer Anaemia Survey ( ECSA ): A large, multinational, prospective survey defining the prevalence, incidence, and treatment of anaemia in cancer patients. Eur J Cancer, 2004, 40:2293-2306. 被引量:1
  • 2Gropman JE, Itri LM. Chemotherapy-induced anaemia in adult: incidence and treatment. J Natl Cancer Inst, 1999,91 : 1616-1634. 被引量:1
  • 3陆晔,潘湘涛,王金湖,程旭,李蓉,严敏,陈丽玉.癌性贫血时血清促红细胞生成素变化的相关研究[J].现代保健(医学创新研究),2007(10Z):22-24. 被引量:10
  • 4Littlewood TJ,Bajetta E, Nortier JW, et al. Effects of epoetin alfa on hematologic parameters and quality of life in cancer patients receiving nonplatinum chemotherapy: results of a randomized, double-blind placebo-controlled trail.J Clin Oncol, 2002, 20:601-603. 被引量:1
  • 5庞丹梅,卫光宇,李精明,陈泽程,唐溢聪,梁剑苗,招丽蓉.内源性红细胞生成素水平与癌性贫血关系的临床分析[J].肿瘤防治杂志,2005,12(17):1304-1306. 被引量:9
  • 6顾琳萍,陆舜.贫血与肺癌[J].临床肿瘤学杂志,2007,12(6):401-406. 被引量:8
  • 7Arslan M,Evrensel T, Kurt E, et al. Comparison of the serum erythropoietin levels in chemotherapy-naive and cisplatin-treated cancer patients. Neoplasma, 2005,52:43-45. 被引量:1
  • 8Kostova G,Siljanovski N. Erythropoietin production in patients with malignant lymphoma. Prilozi, 2005, 26:157-168. 被引量:1
  • 9Braczkowski R, Romanawsky W, Danikiewicz A, et al. Decrease of erythropoietin level by human recombinant turnout necrosis factor alpha (hrec TNFalpha) in patients with advanced cancer. J Biol Regul Homeost Agents,2001, 15: 366-369. 被引量:1
  • 10Littlewood TJ, Zagari M, Pallister C, et al. Baseline and early treatment factors are not clinically useful for predicting individual response to erythropoietin in anemic cancer patients. Oncologist, 2003,8 : 99-107. 被引量:1

二级参考文献59

  • 1李美红,缪泽鸿,丁健.靶向肿瘤缺氧[J].中国癌症杂志,2004,14(5):486-489. 被引量:6
  • 2Reed W R, Hussey D H, DeGowing R L, et al. Implications of the anemia of chronic disorders in patients anticipating radiotherapy[J]. AmJ MedSci, 1994, 308(1): 9-15. 被引量:1
  • 3Quirt I, Robeson C, Lau C Y, et al. Epoetin alfa therapy in creases hemoglobin levels and improves quality of life in patients with cancer related anemia who are not receiving chemotherapy and patients with anemia who are receiving chemotherapy[J]. JClin Oncol, 2001, 19(21) :4126-4134. 被引量:1
  • 4Petersdorf S H, Dale D C. The biology and clinical applications of erythropoietin and the colony-stimulating factors[J]. Adv Intern Med, 1995,40: 395 - 428. 被引量:1
  • 5Spivak J L. Recombinant human erythropoietin and anemia of cancer[J]. Blood,1994,84(4) :997-1004. 被引量:1
  • 6Ludwig H, Fritz E, Leitgeb C, et al. Prediction of response to erythropoietin treatment in chronic anemia of cancer[J]. Blood 1994, 84(4): 1056 1063. 被引量:1
  • 7Ludwig H, Fritz E. Anemia in cancer patients[J]. Semin On col,1998,25(Suppl 7) :2-6. 被引量:1
  • 8Littlewood T J, Bajetta E, Nortier J W R, et al. Effect of epoetin alfa on hematologic parameters and quality of life in cancer patients receiving non platinum chemotherapy: results of a randomized, double-blind, placebo-controlled trial [J]. J Clin Oncol, 2001, 19(11):2865-2874. 被引量:1
  • 9Means R T, Krants S B. Inhibition of human erythroid colonyforming units by gamma interferon can be corrected by recombinant human erythropoietin [J]. Blood, 1991, 78(10): 2564-2567. 被引量:1
  • 10Noble J.Second-line or subsequent systemic therapy for recurrent or progressive non-small cell lung cancer:A systematic review and practice guideline[J].Journal of Thoracic Oncology,2006,1(9):1042-1058. 被引量:1

共引文献20

同被引文献17

  • 1庞丹梅,卫光宇,李精明,陈泽程,唐溢聪,梁剑苗,招丽蓉.内源性红细胞生成素水平与癌性贫血关系的临床分析[J].肿瘤防治杂志,2005,12(17):1304-1306. 被引量:9
  • 2La Ferla K,Reimann C,Jelkmann W,et al. Inhibition of eryth-ropoietin gene expression signaling involves the transcription fac-tors GAT A-2 and NF-kappaB [ J] . FASEB J, 2002 , 16(13):1811 -1813. 被引量:1
  • 3Waters JS,0’ Brien ME,Ashley S. Effects of epoetin alfa onhematologic parameters and quality of life in cancer patients re-ceiving nonplatinum chemotherapy : results of a randomized,double -blind, placebo-controlled trial [ J] . J Clin Oncol, 2002,20(2) :601 -603. 被引量:1
  • 4Kostova G, Siljanovski N. Erythropoietin production in patientswith malignant lymphoma [ J]. Prilozi,2005,26 ( 2 ) : 157 -168. 被引量:1
  • 5Bowen DT,Janowska-Wieczorek A. Serum erythropoietin follow-ing cytostatic therapy [ J]. J Haematol, 1990, 74 ( 3 ) : 372 -373. 被引量:1
  • 6Ohtsu A,Shah MA,Van Cutsem E. Bevacizumab in combination with chemotherapy as first-line therapy in ad-vanced gastric cancer:a randomized,double-blind,placebo-controlled phase Ⅲ study[J].{H}Journal of Clinical Oncology,2011,(30):3968-3976. 被引量:1
  • 7Xu JW,Li CG,Huang XE. Ubenimex capsule im-proves general performance and chemotherapy related tox-icity in advanced gastric cancer cases[J].{H}Asian Pacific Journal of Cancer Prev,2011,(04):985-987. 被引量:1
  • 8廖辉,骆益宙,黄璜,刘曼佳,余浩,赵怡,张义芳.586例肿瘤患者贫血发生率调查[J].癌症进展,2007,5(6):582-584. 被引量:10
  • 9冯岗,邓文斌,唐桦,王晋,张羽,杜小皮,姚兵,李慧,唐诗添.恶性肿瘤患者促红细胞生成素浓度检测和相关性分析[J].四川医学,2008,29(12):1604-1605. 被引量:4
  • 10刘长民,袁苏徐,徐红,李道明,冯军,陈小玲.贫血对乳腺癌辅助化疗疗效和预后的影响[J].实用癌症杂志,2009,24(2):162-164. 被引量:8

引证文献2

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部